Biopharma company UCB is beating out its competitors when it comes to customer experience (CX) among healthcare professionals (HCP), according to a recent survey out of DT Consulting, an Indegene ...

Amgen Inc , UCB SA and Takeda Pharmaceuticals Inc on Monday launched a global trial to identify whether any of three different drugs can reduce the severity of COVID-19 in hospitalized patients by ...

UCB Pharma and Tanner Pharma Group announce a partnership in Southeast Asia to enable access to innovative treatments for patients with epilepsy.

From Hidden to Heard’ campaign included a fashion runway on which 13 HS patients began walking in gowns emblazoned with ...

Combined net sales for these medicines in China for 2023 were 131 million euros. For 2025, a marginal dilution of the adjusted EBITDA margin is anticipated. The market is reacting to Powell’s speech.

DelveInsight’s “Crohn's Disease Market Insights, Epidemiology, and Market Forecast–2034” provides a comprehensive analysis of ...

Parkinson’s disease (PD) is a neurodegenerative disease of the central nervous system characterized by the loss of dopaminergic neurons in the substantia nigra and the abnormal aggregation of ...

Since the appointment of Bruno Holthof as Chairman of the Board of Directors of the company in April 2025, the company's board has continued to strengthen its expertise in the biopharma field. This ...

LONDON (MarketWatch) -- Belgium's UCB said it's agreed to buy Schwarz Pharma for 4.4 billion euros ($5.6 billion) in cash and shares, which is a 20% premium to Friday's close. UCB is offering 50 euros ...

Ra Pharmaceuticals Inc (NASDAQ:RARX) announced an agreement to be acquired by Belgian biopharma UCB for $48 per share in cash or $2.5 billion in total. The boards of both companies approved the ...

Pharma firm UCB, which has previously advertised Bimzelx for treatment of psoriasis -- including this spot that debuted during last year’s Oscars -- and for psoriatic arthritis-- has extended its “Get ...